Clinical Trial Update: A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety of the triple combination elexacaftor/tezacaftor/ivacaftor in participants with cystic fibrosis has completed and posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Elexacaftor-Tezacaftor-Ivacaftor (elexacaftor; tezacaftor; ivacaftor)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-11